Press Release May 13 2025
Filed with NSE · · 6 pages · English
Summary by 6ix AI
The report indicates a significant increase in income from operations and profit after tax compared to the previous year. The company also announced a final dividend recommendation for the financial year, subject to shareholder approval.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Earlier from Cipla
- Press Release Jan 28 2025
- Press Release Oct 29 2024
- Press Release Jul 26 2024
- Cipla: Orchid Pharma partners with Cipla to launch antibiotic Cefepime - Enmetazobactam in India
- Cipla signs a non-exclusive patent license agreement with Takeda to commercialize Vonoprazan drug in India
Later from Cipla
- Press Release Jul 25 2025
- Cipla Expands Fall River Operations in USA, Announces Upcoming Hiring for Various Roles
- Press Release Oct 30 2025
- Cipla USA Strengthens Lung Leadership with Community Wellness Initiatives
- Press Release Jan 23 2026
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla